Skip to main content

Advertisement

Table 1 Main clinical characteristics of PD patients

From: Structural alterations of the intestinal epithelial barrier in Parkinson’s disease

  Age Sex Disease duration (years) Cumulative lifetime dose of L-dopa (mg)
1 70 F 2 0
2 64 M NK NK
3 70 M NK NK
4 66 M 23 66111000
5 47 F 2 0
6 62 M 4 3823375
7 74 M 13 1505625
8 53 M 4 2372500
9 69 M 2.5 273750
10 43 F 11 508050
11 67 M 2.3 0
12 58 M 7 2135250
13 58 M 9 1533000
14 72 F 14 1442662.5
15 64 M 4 492750
16 64 M 10 355875
17 56 M NK NK
18 66 M 4.6 0
19 62 M 26 1560375
20 70 F 2.2 219000
21 57 M 1.8 0
22 58 M 13 2007500
23 50 M 8 1286625
24 69 F 28 3759500
25 62 M 8 511000
26 56 F 8 1241000
27 46 M 10 1213625
28 56 F 8.4 866875
29 58 F 4.8 447125
30 54 M 24 3085423
31 58 M 10 3374130
  1. NK: not known.